Efficacy of the tetravalent protein COVID-19 vaccine, SCTV01E: a phase 3 double-blind, randomized, placebo-controlled trial.
Zhang R, Zhao J, Zhu X, Guan Q, Liu S, Li M, Gao J, Tan J, Cao F, Gan B, Wu B, Bai J, Liu Y, Xie G, Liu C, Zhao W, Yan L, Xu S, Qian G, Liu D, Li J, Li W, Tian X, Wang J, Wang S, Li D, Li J, Jiao Y, Li X, Chen Y, Wang Y, Gai W, Zhou Q, Xie L.
Zhang R, et al. Among authors: gai w.
Nat Commun. 2024 Jul 24;15(1):6255. doi: 10.1038/s41467-024-49832-7.
Nat Commun. 2024.
PMID: 39048547
Free PMC article.
Clinical Trial.